A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium
By C. Marshall, D. Howrigan, Daniele Merico, B. Thiruvahindrapuram, Wenting Wu, Douglas S. Greer, D. Antaki, A. Shetty, P. Holmans, D. Pinto and 259 more. bioRxiv, 2016
1,284 citations recorded by the source corpus.
Genomic copy number variants (CNVs) have been strongly implicated in the etiology of schizophrenia (SCZ). However, apart from a small number of risk variants, elucidation of the CNV contribution to risk has been difficult due to the rarity of risk alleles, all occurring in less than 1% of cases. We sought to address this obstacle through a collaborative effort in which we applied a centralized analysis pipeline to a SCZ cohort of 21,094 cases and 20,227 controls. We observed a global enrichment of CNV burden in cases (OR=1.11, P=5.7e−15), which persisted after excluding loci implicated in previous studies (OR=1.07, P=1.7e−6). CNV burden is also enriched for genes associated with synaptic function (OR = 1.68, P = 2.8e−11) and neurobehavioral phenotypes in mouse (OR = 1.18, P=7.3e−5). We identified genome-wide significant support for eight loci, including 1q21.1, 2p16.3 (NRXN1), 3q29, 7q11.2, 15q13.3, distal 16p11.2, proximal 16p11.2 and 22q11.2. We find support at a suggestive level for nine additional candidate susceptibility and protective loci, which consist predominantly of CNVs mediated by non-allelic homologous recombination (NAHR).
Subfields: Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/2170630b3544be562cf6151f612e80ce53c94f53
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Huaiyu Mi
- Yang I Li
- G. Feng
- Danielle Posthuma
- Patrick F. Sullivan
- Jordan W. Smoller
- Tilmann Achsel
- R. Malenka